These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37587061)

  • 1. Sodium Bicarbonate Nanoparticles for Amplified Cancer Immunotherapy by Inducing Pyroptosis and Regulating Lactic Acid Metabolism.
    Ding B; Zheng P; Tan J; Chen H; Meng Q; Li J; Li X; Han D; Li Z; Ma X; Ma P; Lin J
    Angew Chem Int Ed Engl; 2023 Oct; 62(40):e202307706. PubMed ID: 37587061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium Citrate Nanoparticles Induce Dual-Path Pyroptosis for Enhanced Antitumor Immunotherapy through Synergistic Ion Overload and Metabolic Disturbance.
    Li J; Ding B; Tan J; Chen H; Meng Q; Li X; Zheng P; Ma P; Lin J
    Nano Lett; 2023 Nov; 23(21):10034-10043. PubMed ID: 37903236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable Upconversion Nanoparticles Induce Pyroptosis for Cancer Immunotherapy.
    Ding B; Sheng J; Zheng P; Li C; Li D; Cheng Z; Ma P; Lin J
    Nano Lett; 2021 Oct; 21(19):8281-8289. PubMed ID: 34591494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZIF-8 Nanoparticles Evoke Pyroptosis for High-Efficiency Cancer Immunotherapy.
    Ding B; Chen H; Tan J; Meng Q; Zheng P; Ma P; Lin J
    Angew Chem Int Ed Engl; 2023 Mar; 62(10):e202215307. PubMed ID: 36629270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroptosis: A road to next-generation cancer immunotherapy.
    Fang Y; Tang Y; Huang B
    Semin Immunol; 2023 Jul; 68():101782. PubMed ID: 37302166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed Targeting Pyruvate Metabolism Therapy Amplified Single-Atom Nanozyme-Activated Pyroptosis for Immunotherapy.
    Niu R; Liu Y; Xu B; Deng R; Zhou S; Cao Y; Li W; Zhang H; Zheng H; Song S; Wang Y; Zhang H
    Adv Mater; 2024 Jun; 36(24):e2312124. PubMed ID: 38314930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer.
    Wang M; Wu M; Liu X; Shao S; Huang J; Liu B; Liang T
    Adv Sci (Weinh); 2022 Oct; 9(29):e2202914. PubMed ID: 35981886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mitochondria-Targeted NIR-II AIEgen Induced Pyroptosis for Enhanced Tumor Immunotherapy.
    Yu K; Ye B; Yang H; Xu X; Mao Z; Zhang Q; Tian M; Zhang H; Zhang H; He Q
    Adv Healthc Mater; 2023 Nov; 12(29):e2301693. PubMed ID: 37285905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy.
    Zhao P; Wang M; Chen M; Chen Z; Peng X; Zhou F; Song J; Qu J
    Biomaterials; 2020 Sep; 254():120142. PubMed ID: 32485591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway.
    Feng Z; Chen G; Zhong M; Lin L; Mai Z; Tang Y; Chen G; Ma W; Li G; Yang Y; Yu Z; Yu M
    Biomaterials; 2023 Nov; 302():122333. PubMed ID: 37738743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory-Photodynamic Nanostimulators for Invoking Pyroptosis to Augment Tumor Immunotherapy.
    Qiu W; Su W; Xu J; Liang M; Ma X; Xue P; Kang Y; Sun ZJ; Xu Z
    Adv Healthc Mater; 2022 Nov; 11(21):e2201233. PubMed ID: 36049144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas-Amplified Metalloimmunotherapy with Dual Activation of Pyroptosis and the STING Pathway for Remodeling the Immunosuppressive Cervical Cancer Microenvironment.
    Liu L; Lei H; Hou G; Zhang L; Chen Y; Lu Y; Pei Z; Ge J; Wu J; Zhou J; Cheng L
    ACS Nano; 2024 May; 18(20):12830-12844. PubMed ID: 38709246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-Infrared Light-Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy.
    Zhu G; Zheng P; Wang M; Xie Y; Sun Q; Gao M; Li C
    Adv Healthc Mater; 2024 Feb; 13(4):e2302095. PubMed ID: 37975590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate.
    Lu Y; Xu F; Wang Y; Shi C; Sha Y; He G; Yao Q; Shao K; Sun W; Du J; Fan J; Peng X
    Biomaterials; 2021 Nov; 278():121167. PubMed ID: 34624752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Mild Hyperthermia Hollow Carbon Nanozyme as Pyroptosis Inducer for Boosted Antitumor Immunity.
    Tao N; Jiao L; Li H; Deng L; Wang W; Zhao S; Chen W; Chen L; Zhu C; Liu YN
    ACS Nano; 2023 Nov; 17(22):22844-22858. PubMed ID: 37942890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.
    Li L; Tian H; Zhang Z; Ding N; He K; Lu S; Liu R; Wu P; Wang Y; He B; Luo M; Peng P; Yang M; Nice EC; Huang C; Xie N; Wang D; Gao W
    ACS Appl Mater Interfaces; 2023 Jan; 15(1):452-468. PubMed ID: 36538368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na
    Liu Y; Zhen W; Wang Y; Song S; Zhang H
    J Am Chem Soc; 2020 Dec; 142(52):21751-21757. PubMed ID: 33337859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
    Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
    Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Destructive Copper Carriers Induce Pyroptosis and Cuproptosis for Efficient Tumor Immunotherapy Against Dormant and Recurrent Tumors.
    Qiao L; Zhu G; Jiang T; Qian Y; Sun Q; Zhao G; Gao H; Li C
    Adv Mater; 2024 Feb; 36(8):e2308241. PubMed ID: 37820717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.